Daily Updates
BioMed Nexus Update: Feb 14 News & Tools
Concord Biotech Plummets: Shares crashed 27% by Feb 14, capping a brutal week after a failed trial sank hopes—smallcap biotech’s reeling. Economic Times calls it
BioMed Nexus Daily Updates brings you the latest breakthroughs, trends, and news in Biotech, MedTech, and Pharma—delivered fresh every day. From cutting-edge innovations to industry shifts, our concise recaps keep you ahead in a fast-moving field. Join 20,000+ subscribers.
Concord Biotech Plummets: Shares crashed 27% by Feb 14, capping a brutal week after a failed trial sank hopes—smallcap biotech’s reeling. Economic Times calls it
Latent Labs Unveils AI: On Feb 13, Latent Labs launched an AI platform targeting proteins and RNA for drug discovery, boasting 30% faster hit rates.
Pharma Bribery Risk Looms: Trump’s Feb 12 executive order paused enforcement of the Foreign Corrupt Practices Act, stirring fears of a bribery surge in global